Phosphohistidine-containing protein

Phosphohistidine-containing proteins are defined by the **posttranslational phosphorylation of histidine** residues. This modification commonly occurs at either the 1- or 3-nitrogen of the imidazole ring, yielding **1-phosphohistidine (1-pHis)** or **3-phosphohistidine (3-pHis)** isomers[2][5][7]. Phosphohistidine is highly unstable at low pH and high temperature, making it difficult to study and quantify[2][5]. These proteins play roles in **signal transduction**, **cell cycle regulation**, and **ion channel activity**, among other processes. Known examples include metabolic enzymes (e.g., nucleoside diphosphate kinases) and ion channels such as **Potassium channel subfamily K member 4 (SK4)** and **Transient receptor potential cation channel, subfamily V, member 5 (TRPV5)**, regulated by the phosphorylation status of histidine residues[3][6]. Although not yet targeted by drugs or clinically validated as biomarkers, advances in analytical tools may enable further investigation of their potential in disease and therapy[2][5][6]. **Note:** Phosphohistidine-containing proteins themselves are not a singular molecular target but a broad class distinguished by a modification; therapeutic or research focus should specify the actual protein of interest[2][5][6].

Other names

Phosphohistidine proteinpHis-containing proteinhistidine-phosphorylated protein

Currently limited to experimental antibodies and research probes that recognize the phosphohistidine modification; Modulation would theoretically involve inhibition or enhancement of histidine kinases or phosphatases, affecting downstream processes[3][6]